Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen

Drug Development and Industrial Pharmacy

Volumn 34, Issue 4, 2008, Pages 453-458

  Han, Fei ^a   Li, Sanming ^a   Yin, Ran ^a   Shi, Xiaolei ^a   Jia, Qiang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Flurbiprofen; In vitro permeation; Nanostuctured lipid carriers; Transdermal

Indexed keywords

DRUG CARRIER; FLURBIPROFEN; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PH; RAT; STORAGE TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG CARRIERS; DRUG STABILITY; DRUG STORAGE; FLURBIPROFEN; HYDROGEN-ION CONCENTRATION; LIPIDS; MALE; NANOSTRUCTURES; PARTICLE SIZE; RATS; RATS, WISTAR; SKIN ABSORPTION; TEMPERATURE;

EID: 42049113206     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701833708     Document Type: Article

References (26)

1. Constantinides, P. P., & Yiv, S. H. (1995). Particle size determination of phase-inverted water-in-oil emulsions under different dilution and storage conditions. Int. J. Pharm., 115, 225-234.
2. Cui, Z, & Mumper, R. J. (2002). Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses. J Pharm Pharmacol., 54, 1195-1203.
3. Danino, D., Talmon, Y., & Zana, R., (1997). Vesicle-to-micelle transformation in systems containing dimeric surfactants. J. Colloid. Interface. Sci., 185, 84-93.
4. Fei, H., Sanming, L., Ran, Y., Hongzhuo, L., & Lu, X. (2008). Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf. A: Physicochem. Eng. Aspects., 315, 210-216.
5. Fry, D. W., White, J. C., & Goldman, I. D. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. J. Anal. Biochem., 90, 809-815.
6. FuQiang, H. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B: Biointerfaces, 45, 167-173.
7. Hiemenz, P. C., & Rajagopalan, R. (1997). Principles of colloidal and surface chemistry (3rd ed; pp. 270-271). New York: Marcel Dekker.
8. Jenning, V., & Gohla, S. (2001). Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencaps., 18, 149-158.
9. Jenning, V., Schäfer-Korting, M., & Gohla, S. (2000). Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Control. Release., 66(2), 115-126.
10. Kitagawa, H., Sakai, T., Saito, H., Mori, M., Tazoe, R., Sugibayashi. T., & Nomura, A. (1993). Anti-inflammatory and analgesic actions and skin irritation of flurbiprofen by dermal application. Lyakuhin Kenkyu., 13, 869-878.
11. Kyuki, K., Tsurumi, K., Fujimura, H., Masumoto, S., & Hashimoto, Y. (1984). Anti-inflammatory effect of flurbiprofen for dermal application (FP-A). Iyakuhin Kenkyu., 15, 293-298.
12. Lee, D. J., Burt, C. T., & Koch, R. L. (1992). Percutaneous absorption of flurbiprofen i n the hairless rat measured in vivo using 19F magnetic resonance spectroscopy. J. Invest. Dermatol., 99, 431-434.
13. Masumoto, S., Akiba, T., Okumura, M., Ichikawa, K., & Hashimoto, Y. (1982). Anti-inflammatory effect of flurbiprofen by topical application. Iyakuhin Kenkyu., 13, 878-885.
14. McNeill, S. C., Potts, R. O., & Francoeur, M. L. (1992). Local enhanced topical delivery (LETD) of drugs: Does it truly exist? Pharm. Res., 9, 1422-1427.
15. Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., zur Mühlen, A., Weyhers, H., Freitas, C., & Rühl, D. (1995). Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm., 41(1), 62-69.
16. Müller, B. W., & Müller, R. H. (1984). Particle size distributions and particle size alterations in microemulsions. J. Pharm. Sci., 73(7), 919-922.
17. New, R. R. C. (1990). Liposomes: A practical approach. Oxford: Oxford University Press.
18. Poul, J., West, J., Buchanan, N., & Grahame, R. (1993). Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. Br. J. Pharmatol., 32, 1000-1003.
19. Radomska, S. A., & Müller, R. H. (2006). Chemical stability of lipid excipients in SLN-production of test formulations, characterization and short-term stability. Pharmazie., 61(5), 431-437.
20. Reich, G. (1997). In vitro stability of poly (D, L-lactide) and poly (D, L-lactide)/ poloxamer nanoparticles in gastrointestinal fluids. Drug. Dev. Ind. Pharm., 23(12), 1191-1198.
21. Santos Maia, C., Mehnert, W., & Schäfer-Korting, M. (2000). Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm., 196(2), 165-167.
22. Siekmann, B., & Westesen, K. (1994). Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol I. Preparation and particle size determination. Pharm. Pharmacol. Lett., 3, 194-197.
23. Souto, E. B., & Müller, R. H. (2006a). The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie., 61(5), 431-437.
24. Souto, E. B., & Müller, R. H. (2006b). Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul., 23(4), 377-388.
25. Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm., 27, 71-77.
26. Wissing, S. A., Lippacher, A., & Müller, R. H. (2001). Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J. Cosmet. Sci., 52, 313-323.